1Année·

Valuation Healthcare sector - Goldman Sachs

9
5 Commentaires

image de profil
I still have one US pharma share on my buy list.
But I'm wondering whether I should get in before August.
•
2
•
image de profil
@Tenbagger2024 I don't think anyone can answer that 😁. I think the healthcare sector for diversification is certainly not a mistake at the moment.
•
1
•
image de profil
@BamBamInvest However, there will probably be significant gaps in developments between pharma, biotech, medtech and health insurers/healthcare.

For my taste, the assessments of the sector have been far too crude here recently and little substantiated information has been provided other than arguments of size and relevance for individual market players (cf. also LVMH hype a few months ago, where the key argument was always: hey, come on, it's LVMH, what could possibly go wrong🫣).
•
2
•
Voir une réponse de plus
Utilisateur supprimé
1Année
Le commentaire a été supprimé
image de profil
@Michey777 I see it the same way 👌
••
Participez à la conversation